Patents expiring in 2030

US 7683080

Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7683033

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7683041

Microgel particles for the delivery of bioactive materials

The Regents of the University of California · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7682607

Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

The Regents of the University of California · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7683046

Benzodiazepine compositions for treating epidermal hyperplasia and related disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7683103

Dental polymerizable composition

Kuraray Medical Inc. · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7683082

1,2,4-oxadiazole benzoic acid compositions and their use in bioassays

PTC THERAPEUTICS, INC. · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7683173

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7683177

Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7683188

Process for preparation of mycophenolic acid and ester derivatives thereof

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687462

Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition

The Regents of the University of California · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687480

Phosphonate compounds

The Regents of the University of California · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687481

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

Jenrin Discovery, LLC · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687625

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687638

Dipeptidyl peptidase inhibitors

Takeda San Diego, Inc. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687459

Arylalkoxyl hepatitis C virus protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687660

Process for preparing intermediates of HMG-CoA reductase inhibitors

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687642

Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687519

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687506

Selective serine/threonine kinase inhibitors

The Regents of the University of California · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687622

Process for preparing quetiapine fumarate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687610

Human chorionic gonadotropin superagonists

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687521

Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Theravance, Inc. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7687500

Substituted oxetanes, method of making, and method of use thereof

UNIVERSITY OF CONNECTICUT · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691832

Methods of treatment of inflammatory diseases

The Board of Regents of the University of Oklahoma · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691878

Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7692009

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7692008

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7692010

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691885

Pyridones useful as inhibitors of kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691902

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691582

Methods of secretory vimentin detection and modulation

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691895

Thrombopoietin activity modulating compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691965

Helical synthetic peptides that stimulate cellular cholesterol efflux

The Regents of the University of California · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691872

Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds

New Century Pharmaceuticals, Inc. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691862

Method and composition for treating periodontal disease

Regena Therapeutics LC · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691824

Compositions and methods for inhibiting expression of a gene from the JC virus

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691853

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691607

Expression system of NELL peptide

The Regents of the University of California · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691579

Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691380

Combined methods for tumor coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691567

Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin

The Board of Regents of the University of Texas System · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7691386

Chimeric papillomavirus-like particles

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7696306

Compositions and methods for preventing or treating cancer

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7696227

Small-molecule inhibitors of the androgen receptor

The Regents of the University of California · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7695737

Spherical composite particles and cosmetics with the particles blended therein

JGC Catalysts and Chemicals Ltd. · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7696244

Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof

The Regents of the University of California · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7696338

Immunotoxin fusion proteins and means for expression thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)